Lesson plan
Robert Devenyi
Robert G. Devenyi is a Canadian vitreoretinal surgeon and Professor of Ophthalmology at the University of Toronto. He is the team ophthalmologist for the Toronto Maple Leafs (NHL) and has treated sports-related eye injuries. Devenyi is the ophthalmologist-in-chief and director of retinal services at the University Health Network (UHN), a healthcare and research institution affiliated with the University of Toronto. He is also co-director of the Donald K. Johnson Eye Institute at Toronto Western Hospital, which focusses on ophthalmic care, education, and vision research. At the University of Toronto, Devenyi supervises vitreoretinal surgery fellowships and has contributed to academic training in ophthalmology. His research covers vitreoretinal diseases, surgical innovations, and retinopathies, with peer-reviewed publications in these areas. Devenyi was the first surgeon in Canada to implant the Argus retinal prosthesis device, designed to restore partial vision in patients blinded by degenerative conditions like Retinitis Pigmentosa. However, the long-term efficacy and accessibility of the prosthesis remains a topic of ongoing research and debate within the medical community.
Article summary
Robert G. Devenyi is a Canadian vitreoretinal surgeon and Professor of Ophthalmology at the University of Toronto. He is the team ophthalmologist for the Toronto Maple Leafs (NHL) and has treated sports-related eye injuries. Devenyi is the ophthalmologist-in-chief and director of retinal services at the University Health Network (UHN), a healthcare and research institution affiliated with the University of Toronto. He is also co-director of the Donald K. Johnson Eye Institute at Toronto Western Hospital, which focusses on ophthalmic care, education, and vision research. At the University of Toronto, Devenyi supervises vitreoretinal surgery fellowships and has contributed to academic training in ophthalmology. His research covers vitreoretinal diseases, surgical innovations, and retinopathies, with peer-reviewed publications in these areas. Devenyi was the first surgeon in Canada to implant the Argus retinal prosthesis device, designed to restore partial vision in patients blinded by degenerative conditions like Retinitis Pigmentosa. However, the long-term efficacy and accessibility of the prosthesis remains a topic of ongoing research and debate within the medical community.
Key claims
No claims recorded.
Discussion questions
- Summarise the article in your own words. Which single claim would you verify first, and why?
- Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
- If two sources disagreed about one of these facts, what would you need in order to trust one over the other?
Bibliography
No sources recorded.
Key claims and bibliography are generated from the same tracked claims and sources as the article page.